Fil LTD Teva Pharmaceutical Industries LTD Transaction History

Fil LTD

$95.5 Billion
Q2 2024

A detailed history of Fil LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Fil LTD holds 2,118,996 shares of TEVA stock, worth $37.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,118,996

Previous 2,396,583 11.58%

Holding current value

$37.1 Million

Previous $33.8 Million 1.83%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $3.55 Million - $4.83 Million	-277,587 Reduced 11.58%	2,118,996 $34.4 Million
Q1 2024 May 13, 2024	BUY	$10.67 - $14.43 $709,426 - $959,421	66,488 Added 2.85%	2,396,583 $33.8 Million
Q4 2023 Feb 13, 2024	BUY	$8.12 - $10.63 $6.16 Million - $8.06 Million	758,432 Added 48.26%	2,330,095 $24.3 Million
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $4.92 Million - $7.04 Million	658,380 Added 72.09%	1,571,663 $16 Million
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $1.59 Million - $2.1 Million	221,298 Added 31.98%	913,283 $6.88 Million
Q1 2023 May 11, 2023	BUY	$8.36 - $11.37 $2.22 Million - $3.03 Million	266,143 Added 62.5%	691,985 $6.12 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $624,790 - $745,033	78,590 Added 22.63%	425,842 $3.88 Million
Q3 2022 Nov 10, 2022	BUY	$6.86 - $11.95 $408,677 - $711,909	59,574 Added 20.71%	347,252 $2.8 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $645,816 - $910,093	87,509 Added 43.72%	287,678 $2.16 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $844,056 - $1.08 Million	115,151 Added 135.44%	200,169 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $9,298 - $11,993	-1,177 Reduced 1.37%	85,018 $681,000
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $52,802 - $64,144	-6,301 Reduced 6.81%	86,195 $840,000
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $194,327 - $226,911	19,629 Added 26.94%	92,496 $916,000
Q1 2021 May 14, 2021	BUY	$10.34 - $12.81 $175,221 - $217,078	16,946 Added 30.3%	72,867 $841,000
Q4 2020 Feb 08, 2021	BUY	$8.61 - $11.04 $42,085 - $53,963	4,888 Added 9.58%	55,921 $540,000
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $77,781 - $115,174	-9,076 Reduced 15.1%	51,033 $460,000
Q2 2020 Aug 13, 2020	SELL	$8.12 - $13.12 $139,664 - $225,664	-17,200 Reduced 22.25%	60,109 $742,000
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $12,108 - $24,344	1,810 Added 2.4%	77,309 $695,000
Q4 2019 Feb 07, 2020	BUY	$6.53 - $10.72 $46,265 - $75,951	7,085 Added 10.36%	75,499 $740,000
Q3 2019 Nov 13, 2019	BUY	$6.16 - $9.6 $36,812 - $57,369	5,976 Added 9.57%	68,414 $471,000
Q1 2019 May 13, 2019	BUY	$15.58 - $20.01 $968,343 - $1.24 Million	62,153 Added 21808.07%	62,438 $979,000
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $1,692 - $2,765	116 Added 68.64%	285 $4,000
Q3 2018 Nov 09, 2018	BUY	$21.06 - $25.65 $3,559 - $4,334	169 New	169 $4,000
Q3 2017 Nov 13, 2017	SELL	$15.41 - $32.17 $215,231 - $449,318	-13,967 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	13,967	13,967 $464,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account